Mapk13 - mitogen activated protein kinase 13 Gene

Also Known as Prkm13

Species: Rattus norvegicus

Gene Type: protein coding
Gene ID: 29513

About Mapk13

Primary_assembly 20: 6,835,320-6,844,222 forward strand.mRatBN7.2:CM026993.1

This gene has 1 transcript (splice variant), 214 orthologues, 21 paralogues and is associated with 1 phenotype. Biased expression in Adrenal (RPKM 272.5), Lung (RPKM 47.) and 3 other tissues.

Summary

Enables ATP binding activity and MAP kinase activity. Involved in protein phosphorylation. Predicted to be active in cytoplasm and nucleus. Orthologous to human MAPK13 (mitogen-activated protein kinase 13). [provided by Alliance of Genome Resources, Apr 2022]

Mapk13 Products (1)

mRNA Protein Name
NM_019231.3 NP_062104.3 mitogen-activated protein kinase 13

Gene Ontology

  • Molecular Function
  • Biological Process
Molecular Function GO Annotation Evidence References Source
enables ATP binding IDA
IDA: Inferred from direct assay
16879317 RGD
enables MAP kinase activity IDA
IDA: Inferred from direct assay
16879317 RGD
Biological Process GO Annotation Evidence References Source
involved in protein phosphorylation IDA
IDA: Inferred from direct assay
16879317 RGD
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern

Mapk13 Protein Structure

STKc_p38delta

STKc_p38delta: cd07879 (8 - 350)

  • 0
  • 100
  • 200
  • 300
  • 366 a.a.
Protein Preferred Names Protein Names

mitogen-activated protein kinase 13

  • MAP kinase 13

  • MAP kinase p38 delta

  • MAPK 13

  • mitogen-activated protein kinase p38 delta

  • stress-activated protein kinase 4

Related Agents

  • Pre-clinical Phase

Pre-clinical Phase

Bioactive Molecules (1)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-18850 MAPK13-IN-1 Inhibitor 98.88% Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens Mapk13 NCBI NCBI:5603